Cellular Biomedicine Group

5Feb

$30.6 million Investment from Sailing Capital Overseas Investment Ltd

19Jan

CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution

28Dec

CBMG Announces Closing of $14.5 Million Private Placement Offering

9Nov

Q3 Financial Results and Recent Operational Highlights

7Nov

Cellular Biomedicine Group Opens its New Shanghai GMP Facility and Joint Laboratory

6Nov

Thermo Fisher Scientific and Cellular Biomedicine Group Announce Strategic Partnership to Develop Manufacturing Processes

22Sep

CBMG Plans Grand Opening of its New Shanghai Facility

14Sep

CBMG To Present At The Cantor Fitzgerald Global Healthcare Conference

8Aug

Second Quarter and First Half 2017 Financial Results and Business Highlights

26Jun

Appointment of Dr. Xia Meng as Chief Operating Officer to Lead Commercialization of the Company’s CAR-T and Stem Cell Products